What is Element Biosciences?
Element Biosciences is a San Diego-based life science company founded in 2017, dedicated to developing groundbreaking DNA sequencing technology. Its innovations are targeted at both the research and diagnostic markets, aiming to provide researchers and clinicians with advanced tools for genomic analysis. The company's core mission revolves around creating disruptive technologies that can accelerate scientific discovery and improve patient outcomes through more precise diagnostics. Element Biosciences operates at the intersection of biology, chemistry, and engineering, striving to overcome existing limitations in DNA sequencing efficiency and cost-effectiveness.
How much funding has Element Biosciences raised?
Element Biosciences has raised a total of $648M across 4 funding rounds:
Series A
$15M
Series B
$80M
Series C
$276M
Series D
$277M
Series A (2019): $15M with participation from Foresite Capital and Venrock
Series B (2020): $80M led by JS Capital LLC, Foresite Capital, Fidelity Management & Research Company, and Venrock
Series C (2021): $276M supported by Janus Henderson Investors, Logos Capital, and Meritech Capital Partners
Series D (2024): $277M featuring Fidelity Investments, Samsung Electronics, Wellington Management, and Foresite Capital
Key Investors in Element Biosciences
Foresite Capital
Foresite Capital is a multi-stage investment firm focused on transforming healthcare and life sciences by investing in companies that utilize biology and big data. The firm targets breakthrough opportunities at the intersection of technology and biotechnology, employing a data science-driven investment approach. Their mission is to address significant unmet needs in healthcare by funding visionary businesses at various stages of their development. Foresite Capital aims to support innovators who are changing the landscape of healthcare through strategic partnerships and deep industry expertise.
Fidelity Investments
Fidelity Investments is an international provider of financial services and investment resources that help individuals and institutions meet their financial objectives.
Wellington Management
Wellington Management Company, LLP is a global, independent investment management firm based in Boston, Massachusetts. It provides institutional clients with portfolio management, research, and tailored investment solutions across equities, fixed income, multi-asset, and alternative strategies.
What's next for Element Biosciences?
With the recent infusion of $277M in a major strategic investment, Element Biosciences is poised for accelerated expansion and technological advancement. This substantial capital injection, contributing to its overall $648M in funding, will likely fuel further research and development, enhance manufacturing capabilities, and broaden market penetration. The company's focus on disruptive DNA sequencing technology positions it to capture significant market share in both research and diagnostics. Future strategic initiatives may include scaling operations, forging key partnerships, and potentially expanding its product portfolio to address emerging needs in the life sciences.
See full Element Biosciences company page
